Up to now, although serum alpha-fetoprotein (AFP) level is a useful tumor marker for the detection and monitoring of HCC, the false negative rate with AFP level alone may be as high as 40% for patients with early stage HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.